Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DistaSense: Two-Center Prospective, Non-Significant Risk (NSR) Study to Evaluate Heart Rate and Respiratory Rate Performance for Life Detection Technologies

NCT07217327 is registered in ClinicalTrials.gov with Life Detection Technologies as lead sponsor.

NCT NCT07217327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07217327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DistaSense: Two-Center Prospective, Non-Significant Risk (NSR) Study to Evaluate Heart Rate and Respiratory Rate Performance for Life Detection Technologies
Lead sponsor
Life Detection Technologies
Phase
Observational
Overall status
Recruiting
Start date
August 13, 2025
Completion date
November 30, 2025
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

detection of heart rate and respiratory rate